Synergistic Effect of Flavonoids and Metformin on Protection of the Methylglyoxal-Induced Damage in PC-12 Neuroblastoma Cells: Structure–Activity Relationship and Potential Target
Molecules · 2024
DOI: 10.3390/molecules29102306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Danyang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian 116024, China. Hauptthemen laut MEDLINE: Metformin, Pyruvaldehyde, Flavonoids, Drug Synergism. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhansheng Zhao, Yuesheng Dong, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Methylglyoxal-induced ROS elevation is the primary cause of neuronal damage. Metformin is a traditional hypoglycemic drug that has been reported to be beneficial to the nervous system. In this study, flavonoids were found to enhance the protective effect of metformin when added at a molar concentration of 0.5%. The structure–activity relationship (SAR) analysis indicated that ortho- substitution in the B ring, and the absence of double bonds between the 2 and 3 position combined with the gallate substitution with R configuration at the 3 position in the C ring played crucial roles in the synergistic effects, which could be beneficial for designing a combination of the compounds. Additionally, the mechanism study revealed that a typical flavonoid, EGCG, enhanced ROS scavenging and anti-apoptotic ability via the BCL2/Bax/Cyto C/Caspase-3 pathway, and synergistically inhibited the expression of GSK-3β, BACE-1, and APP in PC-12 cells when used in combination with metformin. The dose of metformin used in the combination was only 1/4 of the conventional dose when used alone. These results suggested that ROS-mediated apoptosis and the pathways related to amyloid plaques (Aβ) formation can be the targets for the synergistic neuroprotective effects of flavonoids and metformin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian 116024, China.
- Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang 050004, China.
- School of Ocean Science and Technology, Dalian University of Technology, Panjin 124221, China.
ORCID-Profile: Yan Xing, Yongming Bao, Yuesheng Dong
Förderung
- Zhansheng Zhao
- Yuesheng Dong
- Natural Science Foundation of Hebei Province
- Major Science and Technology Projects in Yunnan Province
- Academician (Expert) Workstation Construction Project of Yunnan Province
Zitieren
APA
Zhang, D., He, X., Wang, T., Xing, Y., Xiu, Z., Bao, Y., & Dong, Y. (2024). Synergistic Effect of Flavonoids and Metformin on Protection of the Methylglyoxal-Induced Damage in PC-12 Neuroblastoma Cells: Structure–Activity Relationship and Potential Target. Molecules. https://doi.org/10.3390/molecules29102306
Vancouver
Zhang D, He X, Wang T, Xing Y, Xiu Z, Bao Y, et al. Synergistic Effect of Flavonoids and Metformin on Protection of the Methylglyoxal-Induced Damage in PC-12 Neuroblastoma Cells: Structure–Activity Relationship and Potential Target. Molecules. 2024. doi:10.3390/molecules29102306
BibTeX
@article{Zhang2024,
author = {Zhang, Danyang and He, Xiaoshi and Wang, Ting and Xing, Yan and Xiu, Zhilong and Bao, Yongming and Dong, Yuesheng},
title = {Synergistic Effect of Flavonoids and Metformin on Protection of the Methylglyoxal-Induced Damage in PC-12 Neuroblastoma Cells: Structure–Activity Relationship and Potential Target},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29102306}
}
EUVIMED